Immuron Ltd Sustainability Reports
Immuron Limited is an oral antibody biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies. Its commercial products include Travelan and Protectyn, designed for the prevention and treatment of infectious gastrointestinal diseases.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG001SC08Y5
5 reports from 2017 to 2025
